External validation of a fingertip wearable device for obstructive sleep apnea diagnosis and split-night tracking of CPAP treatment response
Sleep Medicine · 2026-10 · 146 · 109075
DOI: 10.1016/j.sleep.2026.109075 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Sleep Medicine, 2026-10. Verfasst von Ke-Wei Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: PranaQ Pte. Ltd., 9 Straits View, #05-07, Marina One West Towers, 018937, Singapore. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Wearable Electronic Devices, Continuous Positive Airway Pressure. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
STUDY OBJECTIVES: To externally validate a novel Type IV fingertip wearable device, TipTraQ, against polysomnography (PSG) for diagnosing obstructive sleep apnea (OSA) in the western-country population with both AASM AHI1A(3%) and AHI1B(4%) labeling rules. Furthermore, evaluate its ability to dynamically track positive airway pressure (PAP) treatment effectiveness using split-night titration as surrogate with short-term apnea-hypopnea index (AHI) and TipTraQ-derived Respiratory Events Index (TQ-REI) sequences. METHODS: In a prospective study at the Duke Sleep Disorders Center, 198 participants were enrolled, including a diagnostic validation cohort (n = 147) and a split-night titration cohort (n = 29). Short-term AHI and TQ-REI sequences were calculated using a 15-min moving window updated every 5 min to capture respiratory event dynamics. Agreement between TipTraQ and PSG was evaluated using standard performance metrics. RESULTS: In the diagnostic cohort, TipTraQ correlated strongly with PSG for total sleep time (TST; PCC = 0.786) and REM duration (PCC = 0.655). Bland-Altman analysis revealed mean biases of -9.50 min for TST and -9.46 min for REM. Epoch-by-epoch sleep staging (Wake, REM, Non-REM) yielded a Cohen's Kappa of 0.567, with highest sensitivity in non-REM sleep (0.824). TQ-REI correlated highly with AHI under AASM scoring rules (PCC = 0.879 for 1A; 0.910 for 1B). In the titration cohort, TipTraQ maintained consistent performance. Analysis of short-term AHI and TQ-REI sequences demonstrated the device's ability to track respiratory event dynamics, yielding a median PCC of 0.882 (1A) and 0.872 (1B). CONCLUSION: TipTraQ shows strong agreement with PSG for respiratory metrics and moderate agreement with PSG for sleep metrics, and captures temporal dynamics of sleep-disordered breathing events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- PranaQ Pte. Ltd., 9 Straits View, #05-07, Marina One West Towers, 018937, Singapore.
- Department of Neurology, Duke University Medical Center, Durham, NC, 27710, USA.
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, 10029, USA.
- Courant Institute of Mathematical Sciences, New York University, New York, 10012, USA. Electronic address: hw3635@nyu.edu.
Zitieren
APA
Chen, K. W., Husain, A. M., Rapoport, D. M., & Wu, H. T. (2026). External validation of a fingertip wearable device for obstructive sleep apnea diagnosis and split-night tracking of CPAP treatment response. Sleep Medicine, 146, 109075. https://doi.org/10.1016/j.sleep.2026.109075
Vancouver
Chen KW, Husain AM, Rapoport DM, Wu HT. External validation of a fingertip wearable device for obstructive sleep apnea diagnosis and split-night tracking of CPAP treatment response. Sleep Medicine. 2026;146:109075. doi:10.1016/j.sleep.2026.109075
BibTeX
@article{Chen2026,
author = {Chen, Ke-Wei and Husain, Aatif M and Rapoport, David M and Wu, Hau-Tieng},
title = {External validation of a fingertip wearable device for obstructive sleep apnea diagnosis and split-night tracking of CPAP treatment response},
journal = {Sleep Medicine},
year = {2026},
volume = {146},
pages = {109075},
doi = {10.1016/j.sleep.2026.109075}
}
EUVIMED